Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
Joint Authors
Schrock, Lauren E.
House, Paul A.
Garber, Sarah T.
Sivakumar, Walavan
Source
Case Reports in Neurological Medicine
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-01-13
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Factor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates.
The authors report a case of a man who presented with delayed, recurrent intracranial hemorrhage months after successful deep brain stimulator placement for Parkinson disease while on edoxaban for atrial fibrillation.
Further reports on the use of novel anticoagulants after intracranial surgery are acutely needed to help assess the true relative risk they pose.
American Psychological Association (APA)
Sivakumar, Walavan& Garber, Sarah T.& Schrock, Lauren E.& House, Paul A.. 2013. Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement. Case Reports in Neurological Medicine،Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-490960
Modern Language Association (MLA)
Sivakumar, Walavan…[et al.]. Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement. Case Reports in Neurological Medicine No. 2013 (2013), pp.1-4.
https://search.emarefa.net/detail/BIM-490960
American Medical Association (AMA)
Sivakumar, Walavan& Garber, Sarah T.& Schrock, Lauren E.& House, Paul A.. Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement. Case Reports in Neurological Medicine. 2013. Vol. 2013, no. 2013, pp.1-4.
https://search.emarefa.net/detail/BIM-490960
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-490960